Related Experiment Video
Updated: Jun 5, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
The role of TRADD in TRAIL-induced apoptosis and signaling
Xiumei Cao1, Yelena L Pobezinskaya, Michael J Morgan
1Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Abstract:
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily. TRAIL is promising for anticancer therapy because it induces apoptosis in cancer cells with little or no toxicity to normal cells; hence, TRAIL-receptor agonists are currently undergoing clinical trials for cancer treatment. However, many molecular signaling mechanisms in TRAIL signaling are not completely characterized. The functions of adaptor proteins, including TNF-receptor-associated death domain protein (TRADD) and receptor-interacting protein-1 (RIP1) in TRAIL signaling have been controversial. We demonstrate that while wild-type mouse embryonic fibroblasts (MEFs) are completely resistant to TRAIL-induced apoptosis, MEFs derived from Tradd(-/-) mice are hypersensitive to TRAIL (IC(50)~0.5 nM rmTRAIL, 24 h), an effect also seen in primary keratinocytes treated with TRAIL/CHX. Restoration of TRADD in Tradd(-/-) MEFs restores TRAIL resistance, indicating that TRADD plays a survival role in TRAIL signaling. We show that TRADD is recruited to the TRAIL-receptor complex, and RIP1 recruitment is mediated by TRADD. While early activation of the MAP kinase ERK is deficient in Tradd(-/-) cells, the main mechanism for enhanced TRAIL sensitivity is likely due to increased recruitment of FADD to the receptor complex, indicating that TRADD may limit FADD binding within the receptor complex and also mediate RIP1-dependent nonapoptotic signaling events, thus reducing caspase activation and subsequent apoptosis. These novel findings have potential implications for cancer therapy using TRAIL-receptor agonists.
Insights
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) signaling involves TRADD for cell survival. TRADD limits FADD binding, reducing cancer cell apoptosis and impacting TRAIL-based cancer therapies.
Area of Science:
- Cellular and Molecular Biology
- Immunology
- Oncology
Background:
- TRAIL induces cancer cell apoptosis, making it a promising anticancer therapy.
- TRAIL signaling pathways, particularly the roles of adaptor proteins like TRADD and RIP1, are not fully understood.
- TRADD's function in TRAIL-induced apoptosis has been controversial.
Purpose of the Study:
- To investigate the role of TRADD in TRAIL-mediated apoptosis.
- To elucidate the molecular mechanisms by which TRADD influences TRAIL signaling.
- To determine the implications of TRADD's function for TRAIL-based cancer therapies.
Main Methods:
- Utilized wild-type and Tradd(-/-) mouse embryonic fibroblasts (MEFs) and primary keratinocytes.
- Assessed TRAIL-induced apoptosis sensitivity using recombinant mouse TRAIL (rmTRAIL) and cycloheximide (CHX).
- Investigated protein recruitment to the TRAIL-receptor complex using biochemical assays and analyzed MAP kinase ERK activation.
Main Results:
- Tradd(-/-) MEFs exhibited hypersensitivity to TRAIL-induced apoptosis compared to wild-type MEFs.
- TRADD recruitment to the TRAIL-receptor complex was demonstrated, mediating RIP1 recruitment.
- TRADD deficiency led to increased FADD recruitment and reduced early ERK activation, enhancing TRAIL sensitivity.
Conclusions:
- TRADD plays a crucial survival role in TRAIL signaling by limiting FADD binding and mediating RIP1-dependent nonapoptotic pathways.
- TRADD's function in regulating apoptosis has significant implications for the development of TRAIL-receptor agonists in cancer treatment.
- Understanding TRADD's role can help optimize TRAIL-based therapies to overcome resistance and enhance efficacy.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
The Intrinsic Apoptotic Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway
